Drugs based on immunoglobulins (or antibodies) have been known for a long time. At the beginning of the XX century, a drug was invented for the treatment of diphtheria based on the blood serum of those who had been ill. Nowadays, immunoglobulins are used to fight various infectious diseases – tick-borne encephalitis, cytomegalovirus, staphylococcus, as well as as therapy for patients with allergies and primary immunodeficiency. Immunoglobulins also help in the fight against autoimmune diseases such as systemic lupus erythematosus, Guillain–Barre syndrome or Kawasaki syndrome. Today, the pharmaceutical industry can offer a variety of immunopreparations. But doctors are faced with such questions as: what to prescribe, when, how to evaluate the effectiveness, etc.

On November 6, a round table “Medicines based on immunoglobulins” was held, which was attended by immunologists, clinical pharmacologists, infectious disease specialists. The organizers of the round table: immunologists Associate Professor, Ph.D. Yagofarov F.F., Ph.D. Kozubaeva D.B., Abdrachmanova G.Zh., clinical pharmacologist Ph.D. Tuleutaeyva R.E., infectious diseases associate professors, Ph.D. Nuralinova G.I. and Maukayeva S.B. The round table was attended by infectious diseases doctors of the adult department of IB, immunologists, residents in the specialties “Infectious diseases”, “Allergology and immunology”, “Clinical pharmacology”, interns of the GP. During the discussion, such issues as types of biologics, pharmacotherapy and pharmacodynamics, doses and courses of treatment, indications and contraindications to their use, evaluation of the effectiveness of treatment, etc. were touched upon. In conclusion, the dots were placed on i how to properly use immuno drugs based on evidence-based medicine.